Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.

作者: Brian J. Morris , Barbara R. Rose

DOI: 10.1515/CCLM.2007.127

关键词: ObstetricsPredictive value of testsPapillomaviridaeCervical screeningCervical cancer preventionHuman papillomavirusMass screeningGynecologyMedicineSampling (medicine)Cervical cancer

摘要: Cervical screening by Pap smear involves a high rate of false negatives, necessitating frequent testing. Because women do not like the sampling procedure, many avoid being screened. Testing for causative high-risk human papillomavirus (HPV) types, PCR or other technologies, on self-collected (tampon) samples permits to be monitored non-invasively. The negative predictive value HPV testing means greater interval between tests, and thus reduces costs. lends itself primary screening. A kit self-collection return laboratory, followed practitioner notification follow-up if required, should result in wider participation. higher accuracy lead improved cervical cancer prevention.

参考文章(174)
Y. Yasui, S. M. Schwartz, S. M. Schwartz, C. Teh, V. Taylor, V. Taylor, A. Kuniyuki, S.-P. Tu, T. G. Hislop, C. Jackson, M. Deschamps, Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Canadian Journal of Public Health-revue Canadienne De Sante Publique. ,vol. 94, pp. 68- 73 ,(2003) , 10.17269/CJPH.94.365
Michael T. Fahey, Les Irwig, Petra Macaskill, Meta-analysis of Pap Test Accuracy American Journal of Epidemiology. ,vol. 141, pp. 680- 689 ,(1995) , 10.1093/OXFORDJOURNALS.AJE.A117485
Catterina Ferreccio, Rodrigo B Prado, Amaranta V Luzoro, Sandra Ll Ampuero, Peter JF Snijders, Chris JLM Meijer, Salvatore V Vaccarella, Alejandro T Jara, Klaus I Puschel, Sylvia C Robles, Rolando Herrero, Silvia F Franceschi, Jose M Ojeda, None, Population-Based Prevalence and Age Distribution of Human Papillomavirus Among Women in Santiago, Chile Cancer Epidemiology, Biomarkers & Prevention. ,vol. 13, pp. 2271- 2276 ,(2004)
Mark Schiffman, Diane Solomon, None, Findings to date from the ASCUS-LSIL Triage Study (ALTS). Archives of Pathology & Laboratory Medicine. ,vol. 127, pp. 946- 949 ,(2003) , 10.1043/1543-2165(2003)127<946:FTDFTA>2.0.CO;2
Diane M. Harper, Walter W. Noll, Dorothy R. Belloni, Bernard F. Cole, Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences. American Journal of Obstetrics and Gynecology. ,vol. 186, pp. 365- 373 ,(2002) , 10.1067/MOB.2002.121076
Achim Schneider, Heike Hoyer, Beatrix Lotz, Sabine Leistritza, Rosemarie Kühne-Heid, Ingo Nindl, Bernhard Müller, Johannes Haerting, Matthias Dürst, Screening for high‐grade cervical intra‐epithelial neoplasia and cancer by testing for high‐risk HPV, routine cytology or colposcopy International Journal of Cancer. ,vol. 89, pp. 529- 534 ,(2000) , 10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G
Andrea P.S. Damin, Rachid Karam, Claudio G. Zettler, Maira Caleffi, Claudio O.P. Alexandre, Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Research and Treatment. ,vol. 84, pp. 131- 137 ,(2004) , 10.1023/B:BREA.0000018411.89667.0D
Emma J. Crosbie, Henry C. Kitchener, Human papillomavirus in cervical screening and vaccination. Clinical Science. ,vol. 110, pp. 543- 552 ,(2006) , 10.1042/CS20050230
Michael M Cassell, Daniel T Halperin, James D Shelton, David Stanton, Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. ,vol. 332, pp. 605- 607 ,(2006) , 10.1136/BMJ.332.7541.605